Dermapharm Holding SE buy PapaSmurf
Summary
This prediction ended on 06.03.23 with a price of €39.50. With a performance of -4.17%, the BUY prediction by PapaSmurf finished with a loss. PapaSmurf has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. PapaSmurf has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Dermapharm Holding SE | -0.966% | -0.966% | -20.222% |
iShares Core DAX® | 1.175% | -0.931% | 13.543% |
iShares Nasdaq 100 | 1.232% | 9.715% | 34.899% |
iShares Nikkei 225® | 1.563% | 3.040% | 8.943% |
iShares S&P 500 | 0.034% | 5.962% | 27.285% |